The Oncology Institute, Inc. provided earnings guidance for the year 2022. For the year, Revenue expected to be in the range of $270 million to $310 million, representing approximately 33% to 53% growth over 2021 revenue.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4071 USD | -10.17% |
|
-9.53% | -80.04% |
05-14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-80.04% | 32.83M | |
+25.21% | 88.77B | |
-22.28% | 77.04B | |
+5.63% | 26.87B | |
-9.70% | 17.3B | |
0.00% | 16.89B | |
+0.78% | 15.44B | |
-23.68% | 13.16B | |
+70.99% | 13.15B | |
+77.65% | 13.11B |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- The Oncology Institute, Inc. Provides Earnings Guidance for the Year 2022